Short answer
Metabolic surgery uses bariatric procedures, most often gastric bypass or one-anastomosis bypass, primarily to treat type 2 diabetes and metabolic disease. Effects start within days and continue long term. It is not a substitute for endocrinology care — lifelong follow-up is required.
What is this procedure?
Metabolic surgery refers to bariatric procedures used to treat metabolic disease as the primary goal. The mechanisms include reduced caloric intake, changes in gut hormones (GLP-1, PYY), bile-acid signalling and the gut microbiome. Effects on glucose metabolism begin within days, independent of weight loss.
Who may be a candidate?
- Adults with BMI ≥ 35 according to the 2022 ASMBS/IFSO indications.
- Adults with BMI 30–34.9 and type 2 diabetes that is inadequately controlled despite optimal medical therapy.
- Patients with related conditions such as hypertension, dyslipidaemia, NAFLD or obstructive sleep apnoea.
- Patients who can commit to lifelong follow-up with surgery and endocrinology teams.
Multidisciplinary evaluation including endocrinology, nutrition, anaesthesia and psychology is the foundation of any metabolic surgery decision.
Who may NOT be suitable?
- Type 1 diabetes (metabolic surgery is not indicated as a treatment for type 1 diabetes).
- Severe untreated medical or psychiatric disease.
- Active substance/alcohol use disorder.
- Inability to commit to lifelong follow-up and supplementation.
How the procedure is performed
The most common metabolic procedures are Roux-en-Y gastric bypass and one-anastomosis gastric bypass, performed laparoscopically under general anaesthesia. Sleeve gastrectomy also has metabolic effects and may be considered in selected patients. Procedure choice is individualised based on metabolic profile, reflux history, anatomy and patient preference.
Preoperative preparation
Detailed metabolic and cardiovascular work-up: HbA1c, fasting and postprandial glucose, lipid profile, liver function, vitamin/mineral panel, thyroid function, upper GI endoscopy, abdominal ultrasound, chest X-ray, ECG and anaesthesia review. Endocrinology, cardiology and pulmonology consultations as needed. A liver-shrinking diet is followed for 1–2 weeks. Diabetes medications, especially insulin and SGLT2 inhibitors, are adjusted by the team.
Hospital stay
Glucose, fluid and electrolyte management are closely monitored. Early mobilisation begins on the day of surgery. Hospital stay is typically 3–4 nights. Before discharge, the diet plan, supplementation, glucose monitoring and revised diabetes medications are reviewed in detail.
Postoperative nutrition and follow-up
Many patients experience rapid improvement in glucose levels and reduced medication requirement. Continued endocrinology follow-up is essential to safely adjust therapy. Lifelong supplementation, dietitian support and laboratory checks at 3, 6 and 12 months and then yearly are part of standard care.
See also: Nutrition after bariatric surgery.
Possible risks and complications
Risks are those of the underlying bariatric procedure (bleeding, leak, infection, venous thromboembolism) plus metabolic-specific issues: hypoglycaemia, vitamin/mineral deficiencies, dumping syndrome (after bypass) and long-term medication adjustment. Risks are managed through careful selection, sound technique and structured follow-up. Results vary between individuals.
Alternative methods
| Feature | Sleeve Gastrectomy | Gastric Bypass | Mini Bypass | Gastric Balloon |
|---|---|---|---|---|
| Type | Surgical (permanent) | Surgical (permanent) | Surgical (permanent) | Endoscopic (temporary) |
| Average duration | 60–90 min | 2–3 hours | 1.5–2 hours | 20–30 min |
| Hospital stay | 3–4 days | 4–5 days | 3–4 days | Same day / 1 day |
| Mechanism | Restrictive + hormonal | Restrictive + malabsorptive | Restrictive + malabsorptive | Satiety effect |
| Effect on reflux | May increase | May improve | Variable | Limited effect |
| Effect on type 2 diabetes | Marked | Very marked | Marked | Limited / temporary |
| Vitamin & mineral follow-up | Required | Strictly required | Strictly required | Limited |
| Reversibility | No | Limited | Limited | Yes (6–12 mo) |
Table is for information only; method selection is made together with the physician after examination, tests and multidisciplinary evaluation.
Frequently asked questions
What is metabolic surgery?
Metabolic surgery refers to bariatric procedures performed primarily to treat type 2 diabetes and other obesity-related metabolic diseases, not just weight loss. The 2022 ASMBS/IFSO statement supports metabolic surgery in selected patients with BMI 30–34.9 and type 2 diabetes.
Who is a candidate?
Adults with BMI ≥ 35 regardless of comorbidities, and selected patients with BMI 30–34.9 and type 2 diabetes that is not adequately controlled with medical therapy, after multidisciplinary evaluation.
Which procedures are used?
Roux-en-Y gastric bypass and one-anastomosis (mini) gastric bypass are the most commonly used metabolic procedures. Sleeve gastrectomy also has metabolic effects in many patients.
Is diabetes cured?
Some patients achieve diabetes remission, especially when surgery is performed earlier in the disease course. Long-term outcomes vary, and lifelong follow-up with the endocrinology team remains essential.
Related pages
Sources
- • Eisenberg D et al., 2022 ASMBS and IFSO Indications for Metabolic and Bariatric Surgery.
- • Mechanick JI et al., Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures — 2019 Update.
- • World Health Organization — Obesity and overweight fact sheet.
Last updated: 28.06.2026 · Medical content: Op.Dr.Gökhan ATEŞ
Discuss metabolic surgery with the team
Metabolic surgery is a major decision that should always be made together with your endocrinology team. Share your BMI, HbA1c and current medications to request a preliminary assessment.